HOME >> MEDICINE >> NEWS
Drip And Ship: Start Drug Early, Especially If Plan To Transfer Heart Patient To Larger Hospital

DALLAS -- For smaller community hospitals that routinely transfer their sicker heart attack patients to larger tertiary care facilities for advanced treatment, the immediate use of a new anti-platelet drug improves the odds that the patient will not die or suffer a second heart attack within 30 days.

Based on the results of their so-called "Drip and Ship" study, researchers from the Duke Clinical Research Institute (DCRI), further recommend that these smaller hospitals immediately begin infusion of the drug eptifibatide (trade name Integrilin) in their suspected heart attack patients with unstable angina, regardless of whether the hospital transfers the sicker patients to larger facilities.

The international 11,000-patient PURSUIT trial, the results of which were published this summer in the New England Journal of Medicine, demonstrated that eptifibatide significantly reduced the 30-day incidence of death or heart attack in heart patients who were admitted to the hospital with unstable coronary syndromes.

Since the majority of these patients are first seen in smaller community hospitals, the DCRI researchers wanted to know if it mattered when the drug was administered -- before or after transfer.

"For these smaller hospitals, the message is clear -- begin the drug immediately," said study author Dr. Adam Greenbaum. "Furthermore, the decision of whether or not to transfer should be based on clinical considerations. In some cases, it appears that starting the drug at the smaller hospital may even alleviate the need to transfer altogether."

Greenbaum, a cardiology fellow at the DCRI, prepared the results of his study for presentation Tuesday (Nov. 10) at the 71st scientific sessions of the American Heart Association meeting.

Eptifibatide, a class of drug known as platelet glycoprotein IIb/IIIa inhibitors, interrupts the cascade of events that causes platelets circulating in the blood t
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
10-Nov-1998


Page: 1 2

Related medicine news :

1. Starting dose of Lexapro as effective as optimally dosed Zoloft in the treatment of depression
2. Starting beta-blocker before discharge in patients hospitalized for heart failure increases usage
3. Smart Start achieving goals, UNC center report indicates
4. High-achieving children off to a good Head Start academically and socially, but study shows some are not turned on by school
5. Intensive Program Can Help Premature Babies Learn At the Start
6. Stopping High Blood Pressure Drugs May Start A Stroke
7. Positive Results Of Pivotal Phase III Trial With ENBREL In Patients With Early, Active Rheumatoid Arthritis
8. Radon, Especially In Combination With Smoking, Contributes To Lung Cancer Deaths
9. Study: Transferred patients hurt big hospitals rankings
10. The European Society of Cardiology launches Women at Heart
11. Heart surgeons publish death rates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... ... 12, 2017 , ... Health Literacy Innovations (HLI), creator of ... and the Cancer Patient Education Network (CPEN), an independent professional organization that shares ... strategic alliance. , As CPEN’s strategic partner, HLI will help support CPEN ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm ... California Berkeley, and other leading institutions in announcing the launch of the ... change the way animals are raised for food. , Founding members of the ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
(Date:10/7/2017)... 2017   Provista, a proven leader in ... in purchasing power, today announced a new resource area ... Newsroom is the online home for case studies, ... bios, news releases, slideshows and events. ... of resources at their fingertips, viewers can also watch ...
(Date:10/4/2017)... South Korea , Oct. 4, 2017  South ... its next-generation CPR training aide "cprCUBE" on Kickstarter. The ... chest compression during cardiac arrests with better efficiency compared ... It also offers real-time feedback on efficacy of the ... The crowdfunding campaign has a goal to raise $5,000. ...
Breaking Medicine Technology:
Cached News: